Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (4240)	11/28/2001 8:21:35 PM
From: RJMC	Respond to of 5665

Thanks Ice. The new release raised the same question for me. From what I found on a brief search of the web, it sounds like the C44 antigen (variant 6) is found in a number of tumors. In some of the articles I read it sounds like the antibody acts much in the same way as Imclone's anti-EGF product. Looks like the same general set of cancers also. One other cancer that wasn't indicated in the article you found is melanoma. Sounds like the product will be broadly applicable. It is probably something also that would be used in conjunction with other treatments rather than a stand alone treatment. Bob M.